On the feasibility of stereotactic radiosurgery with 5.0 and 10.0 mm mlc leaves as a function of target size and shape

dc.contributor.authorJalbout, Wassim T.
dc.contributor.authorZahr, Jana Abou
dc.contributor.authorYoussef, Bassem Y.
dc.contributor.authorShahine, Bilal H.
dc.contributor.departmentRadiation Oncology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:12:23Z
dc.date.available2025-01-24T12:12:23Z
dc.date.issued2019
dc.description.abstractIntroduction: This study explores the feasibility of SRS/SRT treatment with MLC leaves wider than 2.5 mm at isocenter by inter-comparing treatment plans produced with 2.5, 5.0, and 10.0 mm leaves for various target sizes and shapes. Materials and methods: Forty previously treated patients were re-planned using 2.5, 5.0, and 10.0 mm wide MLC leaves. For each patient, all three plans were evaluated and contrasted between them in terms of five metrics: target dose homogeneity, conformity index, organs at risk dose, dose fall off outside the target, and dose to normal tissues. A regularity index RI was introduced that quantified the degree of target shape irregularity. The effect of target size and shape irregularity on feasibility of 5.0 and 10.0 mm leaves was analyzed. Results: Consistent plan degradation was observed for 10.0 mm (sometimes for 5.0 mm) compared to 2.5 mm MLC in terms of the above five plan metrics, but this degradation was small to clinically insignificant. As an exception, when target (PTV) size was smaller than about 1 cm diameter, clinically significant differences were found between 2.5, 5.0, and 10.0 mm MLC. Conclusion: 5.0 and 10.0 mm MLC can be used in SRS/SRT for targets (PTV) diameter larger than 1 cm. For smaller targets, 2.5 mm MLC is clinically superior, 5.0 is acceptable and 10.0 mm MLC is discouraged in terms of PTV dose conformity. © 2019 Jalbout, Abou Zahr, Youssef and Shahine.
dc.identifier.doihttps://doi.org/10.3389/fonc.2019.00741
dc.identifier.eid2-s2.0-85071670107
dc.identifier.urihttp://hdl.handle.net/10938/32743
dc.language.isoen
dc.publisherFrontiers Media S.A.
dc.relation.ispartofFrontiers in Oncology
dc.sourceScopus
dc.subjectLeaf size
dc.subjectLeaf width
dc.subjectMlc
dc.subjectMultileaf collimators
dc.subjectRadiosurgery
dc.subjectSrs
dc.subjectSrt
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAged
dc.subjectAlgorithm
dc.subjectArticle
dc.subjectBiomechanics
dc.subjectBrain damage
dc.subjectClinical article
dc.subjectClinical target volume
dc.subjectFeasibility study
dc.subjectGamma radiation
dc.subjectHuman
dc.subjectInjury
dc.subjectIntensity modulated radiation therapy
dc.subjectMathematical model
dc.subjectOrgans at risk
dc.subjectPlanning target volume
dc.subjectRadiation dose
dc.subjectRisk factor
dc.subjectStereotactic body radiation therapy
dc.subjectStereotactic radiosurgery
dc.subjectThrombocyte shape
dc.subjectTreatment planning
dc.subjectTumor volume
dc.titleOn the feasibility of stereotactic radiosurgery with 5.0 and 10.0 mm mlc leaves as a function of target size and shape
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2019-3994.pdf
Size:
727.35 KB
Format:
Adobe Portable Document Format